187 results
8-K
EX-99.1
SRDX
Surmodics, Inc.
1 May 24
Updates Fiscal Year 2024 Financial Guidance
7:00am
of fiscal 2023, primarily driven by $1.4 million in catch-up payments reported by customers and growth in customer utilization of Surmodics’ hydrophilic
8-K
EX-99.1
SRDX
Surmodics, Inc.
1 Feb 24
Updates Fiscal Year 2024 Financial Guidance
7:00am
million in the first quarter of fiscal 2023, driven primarily by strong customer demand and favorable order timing for distributed antigen
8-K
EX-99.1
anj6wu9uhwxwj48n
8 Nov 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
la2mfdr8cdc2 o0yov
2 Aug 23
Updates Fiscal Year 2023 Financial Guidance
7:01am
8-K
EX-99.1
qx5yhlz2isbqhp s66zp
8 Jun 23
Regulation FD Disclosure
8:01am
8-K
EX-99.1
muhxte6pz
9 Nov 22
Results of Operations and Financial Condition
7:01am
8-K
EX-10.1
2hntxwbu zt3eh
17 Oct 22
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
xkmnymbrc
27 Jul 22
Results of Operations and Financial Condition
7:35am
8-K
EX-99.1
empmnjfdccgo5z1w
27 Apr 22
Results of Operations and Financial Condition
7:35am
8-K
EX-99.1
i8v60nea0eq1
11 Jan 22
Regulation FD Disclosure
8:30am